Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Changes

8 Jun 2011 07:00

RNS Number : 0396I
Xaar PLC
08 June 2011
 



Xaar plc (the "Company")

 

 

Board Changes

 

 

The Company is pleased to announce the appointment of David Cheesman (68) as a Non-executive Director of the Company with effect from 4 July 2011.

 

Mr Cheesman has several non-executive positions including the Advisory Board of the London Technology Fund and was recently an advisor to Bladon Jets Ltd and Bowman Power Ltd. Between 1988 and 2007, Mr Cheesman worked for several private equity firms including Advent Venture Partners, TriTech Investment Managers and 3i plc. Before joining 3i in 1988 Mr Cheesman was managing director of Dowty Information Systems where he reorganised the management structure and significantly improved profitability. Mr Cheesman has also held several senior management and engineering roles at Prime Computer, Varian/Univac, Computer and Systems Engineering, Honeywell and UKAEA Sellafield. Mr Cheesman, a graduate electrical engineer is a Chartered Engineer and Fellow of the Institution of Engineering and Technology.

 

Mr Cheesman is replacing Robert Ecklemann whose retirement after 6 years as a Non-executive Director was set out in the Company's report and accounts.

 

Mr. Phil Lawler, Chairman, commented: "We are very please to have attracted David to join our board. His vast and in-depth technology experience will help to strengthen the board and I and my fellow board members look forward to working with him.

 

I would also like to take this opportunity to thank Robert Ecklemann for his contributions to the board and the progress Xaar has made in the past six years. The board wishes him continued success in his other ventures."

 

Further information in connection with Mr Cheesman's appointment

 

Details of public company directorships held by Mr Cheesman over the past 5 years are provided below:

 

Celoxica Plc - resigned 2 July 2008

Advent Ltd - resigned 31 December 2007

Advent Fund Managers Ltd - resigned 31 December 2007

Advent 2 Fund Managers Ltd - resigned 31 December 2007

Advent Investments Ltd - resigned 31 December 2007

Advent Management IV Ltd - resigned 31 December 2007

SPI Lasers Plc - resigned 31 October 2007

 

There are no other details to disclose under Listing Rule 9.6.13R.

 

 

For further information, please contact:

 

Xaar plc +44 (0) 1223 423 663

 

Phil Lawler - Chairman

Ian Dinwoodie - Chief Executive

Alex Bevis - Finance Director

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUBRKRANANRAR
Date   Source Headline
13th Mar 200810:21 amRNSDividend Payment Date
13th Mar 20087:01 amRNSFinal Results
19th Feb 20087:00 amRNSNotice of Final Results
8th Feb 20087:00 amRNSCustomer product launch
30th Jan 20087:00 amRNSDirectorate Change
29th Jan 20087:01 amRNSControl change for partner
10th Jan 20087:01 amRNSYear end trading update
9th Jan 20087:00 amRNSHolding(s) in Company
4th Jan 20083:59 pmRNSTotal Voting Rights
2nd Jan 20089:53 amRNSHolding(s) in Company
11th Dec 200712:25 pmRNSHolding(s) in Company
6th Dec 20075:17 pmRNSTotal Voting Rights
30th Nov 200710:26 amRNSHolding(s) in Company
30th Nov 20077:00 amRNSHolding(s) in Company
27th Nov 200710:12 amRNSHolding(s) in Company
31st Oct 20078:30 amRNSHolding(s) in Company
17th Oct 20076:36 pmRNSHolding(s) in Company
15th Oct 20077:00 amRNSAppointment of Director
5th Oct 20075:46 pmRNSDirector/PDMR Shareholding
12th Sep 20077:01 amRNSInterim Results
11th Sep 20077:03 amRNSNew customer product launches
4th Sep 20075:39 pmRNSTotal Voting Rights
3rd Sep 20077:02 amRNSNotice of Interim Results
21st Aug 20075:29 pmRNSHolding(s) in Company
17th Aug 20076:00 pmRNSHolding(s) in Company
17th Aug 20075:40 pmRNSHolding(s) in Company
6th Aug 20077:00 amRNSDirector/PDMR Shareholding
2nd Aug 20074:30 pmRNSTotal Voting Rights
17th Jul 20077:00 amRNSAppointment of R&D Director
13th Jul 200711:05 amRNSHolding(s) in Company
11th Jul 20077:00 amRNSDirector/PDMR Shareholding
11th Jul 20077:00 amRNSTotal Voting Rights
10th Jul 20077:00 amRNSPeriod End Trading Statement
9th Jul 20075:45 pmBUSDutton Associates Announces Investment Opinion: Xaar Plc Rated Buy in Update Report by Dutton Associates
4th Jun 200710:51 amRNSHolding(s) in Company
24th May 20076:11 pmRNSDirector/PDMR Shareholding
24th May 20071:10 pmRNSHolding(s) in Company
23rd May 20077:00 amRNSFacility visit
16th May 20077:01 amRNSAppointment of Chairman
14th May 20077:00 amRNSDirector/PDMR Shareholding
10th May 20076:05 pmRNSDirector/PDMR Shareholding
9th May 20076:19 pmRNSDirector/PDMR Shareholding
1st May 20076:24 pmRNSDirector/PDMR Shareholding
1st May 200711:37 amRNSHolding(s) in Company
24th Apr 200710:20 amRNSDirector/PDMR Shareholding
23rd Apr 200712:56 pmRNSResult of AGM
23rd Apr 20077:01 amRNSAGM Trading Update
13th Apr 20075:00 pmBUSDutton Associates Announces Investment Opinion: Xaar plc Buy Rating Maintained In Update Coverage By Dutton Associates
11th Apr 200711:55 amRNSAnnual Information Update
29th Mar 20071:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.